Neuronetics

Neuronetics

Health Care Equipment & Supplies
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.

$194.7M

Market Cap • 9/28/2026

2003

(23 years)

Founded

2018

(8 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

10,9

P/S

1,3

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,3

EPS

—

Market Cap

Market Cap

194,7M

EV

265,8M

EV/Revenue

1,7

EV/EBITDA

-13,5

EV/EBIT

-11,6

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-8,4%

Total Yield

-8,4%

Payout

0%

Retained Earnings

-473,2M

Profitability

Gross Margin

49,1%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

3,8%

Capex/Revenue

0,6%

Capex/D&A

30,2%

Capex/OCF

-9,2%

SBC/OCF

—

% PPE

20,8%

% Goodwill

18%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

23,3%

CAGR Op. Income 5Y

4,3%

CAGR Net Income 5Y

6,5%

CAGR EPS 5Y

-14,6%

CAGR OCF 5Y

-12,6%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

1,9

Quick Ratio

1,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium